← All organizations

MedAvante

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 1, 2016

Acquired by WIRB-Copernicus Group on May 9, 2017

Timeline

2000s

Jun 1, 2002
MedAvante— Founded

2010s

May 9, 2017
WIRB-Copernicus Group— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

cromoglicic acid

Indications

Studied for

Recent trials (1)

NCT03202147CollaboratorPhase 2Jul 1, 2016

Details

Founded: Hackensack, NJ, US Jun 1, 2002
Last known activity: Jul 1, 2016